Julianne Bruno, Chief Operating Officer at CRISPR Therapeutics AG (CRSP), sold 6,732 shares at $56.09 ($378K) on 2024-06-21, disclosed to the SEC on 2024-06-24.
Open-market sale of $378k CRSP by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.09 | 3,366 | $189K | 50.0% |
| 2 | $56.09 | 3,366 | $189K | 50.0% |
| Total | $56.09 avg | 6,732 | $378K | 100% |
| Filing → |
| CRSP | SELL | 2025-02-19 | $18K | — | Filing → |